Brachioradial Pruritus

Etiology

Although not fully elucidated, current evidence supports a bifactorial pathogenesis for BRP, involving cervical nerve irritation and UVR exposure to the affected region.[10][11][12] Absence of either radiographically apparent cervical pathology or UVR exposure does not exclude the diagnosis.

Most patients with BRP demonstrate cervical spine abnormalities on imaging. Radiographic, computed tomography (CT), or magnetic resonance imaging (MRI) findings frequently reveal degenerative joint disease, disk herniation with nerve impingement, osteoarthritis, or foraminal stenosis. Degenerative joint disease appears to be the most common abnormality identified. Despite the high prevalence of these findings, most patients do not meet diagnostic criteria for cervical radiculopathy. Only a subset of patients with BRP undergo imaging, further complicating the interpretation of the association between cervical pathology and symptomatology. The observed abnormalities may reflect subclinical radiculopathy or incidental degenerative changes rather than a direct causal relationship.

UVR is considered a significant contributing factor in BRP, with many patients reporting symptom exacerbation following sun exposure. The term "brachioradial summer pruritus" has been applied to describe the increased incidence of BRP during warmer months. A subset of histamine-sensitive C fibers mediates the transmission of pruritus, and excessive UVR induces damage and reduction of these fibers. Despite this reduction, patients with BRP frequently experience heightened pruritic sensations after UVR exposure. This abnormal response to a normally nonpruritic stimulus is termed alloknesis. Symptom improvement during colder months and consistent photoprotection further support the role of UVR as a precipitating factor in BRP.

Epidemiology

The prevalence of BRP remains undetermined. Although initially characterized as a tropical disorder, subsequent reports have documented BRP's occurrence in temperate regions. Cases have been identified in the U.S., particularly in California, Massachusetts, North Carolina, Florida, Kansas, and Hawaii.[13][14][15][16][17] BRP typically occurs sporadically, though an autosomal dominant inheritance pattern has been described in 1 family, with 11 affected members across 2 generations.[18]

Clinical manifestations usually arise between the 4th and 6th decades of life. The youngest reported case involved an 18-year-old woman whose mother, sister, and 2 aunts also exhibited symptoms. The condition was first recognized in middle-aged male outdoor workers but has since been reported in both sexes across diverse occupations.[19] BRP has been observed in individuals of all skin types, although those with Fitzpatrick types I to III appear more frequently affected than those with darker skin tones. This phototype distribution supports the etiologic contribution of UVR in BRP pathogenesis.

Pathophysiology

Pruritus in BRP is considered a variant of neuropathic pain, although the precise anatomical site of neural irritation remains under investigation. Two primary hypotheses have been proposed. The first attributes BRP to peripheral cutaneous nerve injury induced by sunlight exposure, whereas the second implicates cervical spine pathology with nerve root involvement. Both mechanisms likely contribute in varying degrees among affected individuals.

BRP appears to represent a primary neuropathy characterized by altered cutaneous innervation.[20] Massey et al reported abnormal thermal and pinprick perception localized to the distribution of the posterior cutaneous nerve of the forearm, which supplies the skin overlying the brachioradialis muscle, the area typically affected by pruritus. Patients have demonstrated cold or heat hyperalgesia within the C5 to C6 dermatomes and pinprick hyperesthesia across the C5 to C8 segments.[21][22][21]

Wallengren et al used neuronally directed antibodies to show that individuals with BRP exhibit a reduction in dermal and epidermal nerve fibers, with this loss occurring exclusively during symptomatic exacerbations.[23][24] De Ridder et al identified selective C-fiber dysfunction at C6 to C8 through quantitative sensory testing and documented improved C-fiber function following intralaminar steroid injection at C6 to C7.[25]

Histopathology

BRP does not exhibit distinctive histopathologic features. Reported microscopic findings include actinic elastosis and reduced density of epidermal and dermal nerve fibers. Actinic elastosis correlates with a history of chronic UVR exposure, supporting a phototoxic contribution to disease pathogenesis. Decreased cutaneous nerve fiber density has also been observed following phototherapy, consistent with UVR-associated exacerbations typically noted during summer months. Evidence suggests that this reduction in innervation occurs predominantly during symptomatic periods, with reinnervation during remission. For this reason, biopsy is recommended while patients are actively symptomatic to optimize diagnostic yield.

History and Physical

Given the wide differential diagnosis of pruritus, a detailed history is critical to prevent unnecessary testing and treatment delays. BRP typically involves the dorsolateral aspect of the arms but may extend to adjacent regions corresponding to the C5 to C6 dermatomes, including the upper arms, shoulders, and neck. In addition to pruritus, patients often report pain, stinging, or tingling in the affected area. Bilateral involvement occurs in approximately 75% of cases.[26][27][28]

Scratching commonly exacerbates discomfort, and many patients identify cooling measures, such as ice packs or cold, damp towels, as the only effective means of relief. Symptoms are usually more pronounced at night and may interfere with sleep. The average duration of symptoms is approximately 4.5 years, although some patients experience persistence for up to 18 years. In rare instances, localized BRP may progress to generalized pruritus.[29]

Affected individuals are frequently outdoor enthusiasts, including bikers, hikers, and tanners, often with a history of significant sun exposure or sunburn. Despite the high prevalence of cervical spine abnormalities on imaging, retrospective studies indicate that few patients report neck pain, spinal narrowing, or trauma.

Physical examination findings of the affected regions are typically unremarkable, without primary cutaneous lesions. Secondary signs, such as excoriations, prurigo nodules, or lichenification, may result from chronic scratching. Confounding factors include coexisting pruritic disorders, dermatologic disease, medication effects, and atypical presentations. Erythema and rash are absent despite symptom severity. Sensory examination may reveal marked heat hyperalgesia in the C5 to C6 dermatomes and pinprick hyperesthesia extending through the C5 to C8 distribution.

Evaluation

Extensive diagnostic evaluation is generally unnecessary in BRP. A detailed history, focused physical examination, and demonstration of the ice-pack sign are typically sufficient to establish the diagnosis. The ice-pack sign is regarded as pathognomonic, characterized by immediate symptom relief upon application of an ice pack to the affected area, followed by prompt recurrence of pruritus after its removal.

Imaging studies, including radiography, CT, and MRI, are seldom indicated. However, MRI is the preferred modality when cervical spine assessment is warranted. Imaging should be considered in patients who fail to respond to standard therapies or experience progressive symptoms to exclude structural lesions, such as tumors, cervical ribs, and evidence of radiculopathy. BRP occurring in individuals with spinal cord injury may suggest syrinx formation.[30]

Basic laboratory testing may be performed to evaluate for alternative causes of chronic pruritus. Neurology referral is appropriate when a central or peripheral neurologic etiology is suspected. Electromyography and nerve conduction velocity studies may demonstrate delayed F-wave responses in the median or ulnar nerves, supporting the diagnosis in diagnostically uncertain cases.[31]

Treatment / Management

Management of BRP involves UVR avoidance, pharmacologic interventions, and, in select refractory cases, surgical treatment. Ice pack application provides rapid symptomatic relief and may be used as an adjunct for acute exacerbations. Although several therapeutic agents have demonstrated benefit, no single treatment has shown consistent efficacy across studies.

Avoidance of UVR remains the primary preventive measure. Strategies include minimizing direct sun exposure, regular application of broad-spectrum sunscreen, and wearing long-sleeved UV-protective clothing. Adherence to these measures may be challenging for individuals who engage in outdoor activities, particularly during the warm summer months.

Topical therapies constitute the 1st-line pharmacologic approach. Options include capsaicin, mild corticosteroids, anesthetic agents, antihistamines, and compounded amitriptyline-ketamine formulations. Early reports identified topical capsaicin as the most frequently prescribed initial therapy. Capsaicin (0.025%-0.05%) acts by depleting substance P, a neurotransmitter involved in the transmission of pain and pruritus, from cutaneous sensory nerve terminals.[32] Several studies have reported symptom improvement within weeks of treatment.[33] Capsaicin patches have also been used as an alternative formulation.[34](B3)

Topical corticosteroids are rarely effective and should be used cautiously, as prolonged or excessive application of superpotent agents can result in cutaneous atrophy. Topical anesthetics such as lidocaine cream or gel, as well as 5% doxepin cream, may provide transient symptomatic relief. Compounded topical amitriptyline hydrochloride and ketamine hydrochloride preparations have demonstrated benefit in refractory cases of BRP.[35]

Among systemic agents, the tricyclic antidepressant amitriptyline has historically been the most frequently prescribed medication for BRP, although gabapentin may offer superior efficacy. Additional oral agents include risperidone, fluoxetine, chlorpromazine, and hydroxyzine. Despite their common use for other pruritic disorders, systemic antihistamines have not demonstrated benefit in BRP for reasons that remain unclear. The most favorable responses have been reported in patients who exhibit severe symptoms or have maintained prolonged treatment courses.

Antidepressant and anticonvulsant agents that modulate neural excitability, such as gabapentin and pregabalin, appear to be the most effective options.[36] A retrospective study from a tertiary center compared pregabalin monotherapy with combination therapy using pregabalin, ketamine, amitriptyline, and lidocaine cream. Both regimens resulted in significant reductions in pruritus, with no appreciable difference in outcomes between groups.[37] Aprepitant, a neurokinin-1 receptor antagonist, has also shown potential efficacy in chronic, treatment-resistant cases.(B2)

Cervical nerve blocks have not demonstrated consistent efficacy in BRP, although cervical spine manipulation has provided symptomatic benefit in some patients.[38] Cutaneous field stimulation has also been explored as a therapeutic option. A study demonstrated that daily 20-minute sessions applied to the affected regions produced marked improvement after approximately 5 weeks of treatment.[39] Acupuncture may likewise afford symptomatic relief in select cases.[40](B2)

Surgical intervention is generally reserved for patients with confirmed cervical radiculopathy, a cervical rib, or a fibrous band compressing the brachial plexus. Surgery may be considered for individuals with severe, refractory symptoms unresponsive to medical or conservative measures.

Nemolizumab, an interleukin-31 receptor α antagonist approved for the treatment of prurigo nodularis and atopic dermatitis in the U.S., did not elicit improvement in a limited case series of BRP, despite its demonstrated efficacy in other pruritic dermatoses. The lack of response may reflect the single-case nature of the report, underscoring the need for larger studies to evaluate its therapeutic potential in this condition.[41](B2)

Differential Diagnosis

The differential diagnosis of BRP encompasses several conditions with overlapping clinical features. Recognition of these distinctions relies on a thorough history, focused physical examination, and, when appropriate, targeted diagnostic studies.

Neurotic excoriations may resemble BRP, as both can present with excoriations on affected areas. However, patients with neurotic excoriation typically exhibit lesions on more accessible body sites. Some authors have proposed a potential overlap or shared pathophysiologic mechanism between these 2 disorders. Notalgia paresthetica is another neuropathic itch disorder characterized by pruritus, paresthesia, hyperesthesia, or discomfort localized to the back. A well-defined hyperpigmented patch is often present over the symptomatic area.[42]

Zoster sine herpete represents an atypical form of herpes zoster in which intense unilateral paresthesia occurs without a cutaneous eruption. When this condition is suspected, diagnostic confirmation may be achieved through direct immunofluorescence using fluorescein-tagged antibodies or polymerase chain reaction assays to detect varicella-zoster virus. Atopic dermatitis may also mimic BRP but typically presents with intense pruritus affecting the flexor surfaces of the elbows. Unlike BRP, tingling sensations are absent in this condition.

Prognosis

Most patients with brachioradial pruritus experience symptom remission. A smaller subset progresses to a chronic course. Prognosis appears to be influenced by emotional or psychiatric comorbidities.

Complications

Psychiatric manifestations, including anxiety and depression, may develop over time in patients with persistent symptoms. Sleep disturbance is common, as the intense tingling, burning, and itching associated with the condition often interrupt nocturnal rest. Frustration is frequent due to the limited efficacy of standard antipruritic therapies.